Conversely, the rising breast cancer burden in low-SDI settings (+ 1.2% APC) mirrors patterns observed in sub-Saharan Africa, where delayed diagnosis and estrogen receptor-negative subtypes dominate—outcomes potentiated by BMI-driven chronic inflammation overriding protective effects of younger age at onset [21]. This evidence concerns the gene ESR1 and breast cancer.